Cyclacel Pharmaceuticals Inc Stock Forecast
Cyclacel Pharmaceuticals Inc stock upgraded to Buy Candidate.
(Updated on Jul 03, 2024)
No changes to the price of Cyclacel Pharmaceuticals Inc stock on the last trading day (Wednesday, 3rd Jul 2024). During the last trading day the stock fluctuated 0% from a day low at $9.41 to a day high of $9.41. The price has been going up and down for this period, and there has been a 22.21% gain for the last 2 weeks.
The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $10.13 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -46.65% during the next 3 months and, with a 90% probability hold a price between $0.215 and $5.40 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
CYCCP Signals & Forecast
The Cyclacel Pharmaceuticals Inc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $9.06 and $7.76. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, July 02, 2024, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for Cyclacel Pharmaceuticals Inc stock
On the downside, the stock finds support just below today's level from accumulated volume at $8.40 and $8.01. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Cyclacel Pharmaceuticals Inc finds support just below today's level at $8.40. If this is broken, then the next support from accumulated volume will be at $8.01 and $7.49.
In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 16.31%
Our recommended stop-loss: $8.88 (-5.64%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 4 days ago.)
Trading Expectations (CYCCP) For The Upcoming Trading Day Of Friday 5th
For the upcoming trading day on Friday, 5th we expect Cyclacel Pharmaceuticals Inc to open at $9.41, and during the day (based on 14 day Average True Range), to move between $8.69 and $10.13, which gives a possible trading interval of +/-$0.721 (+/-7.66%) up or down from last closing price. If Cyclacel Pharmaceuticals Inc takes out the full calculated possible swing range there will be an estimated 15.32% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $9.45 (0.43%) than the support at $8.40 (10.73%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Cyclacel Pharmaceuticals Inc stock A Buy?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.
Current score: 1.650 Buy Candidate Upgraded
Predicted Opening Price for Cyclacel Pharmaceuticals Inc of Friday, July 5, 2024
| Fair opening price July 5, 2024 | Current price |
|---|---|
| $9.41 ( 0%) | $9.41 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for CYCCP
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 9.41 | - |
| R2 | 9.41 | - |
| R1 | 9.41 | - |
| Price | 9.41 | |
| S1 | 9.41 | - |
| S2 | 9.41 | - |
| S3 | 9.41 | - |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 10.70 | 13.71% |
| R2 | 10.00 | 6.27% |
| R1 | 9.45 | 0.425% |
| Price | 9.41 | |
| S1 | 8.40 | -10.73% |
| S2 | 8.01 | -14.88% |
| S3 | 7.49 | -20.40% |
CYCCP Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Jan 12, 2024 | Jan 19, 2024 | Feb 01, 2024 | $0.150 | 0.748% |
| 2 | Sep 06, 2023 | Oct 19, 2023 | Nov 01, 2023 | $0.150 | 2.14% |
| 3 | Jun 13, 2023 | Jul 20, 2023 | Aug 01, 2023 | $0.150 | 0.94% |
| 4 | Mar 08, 2023 | Apr 20, 2023 | May 01, 2023 | $0.150 | 0.85% |
| 5 | Dec 13, 2022 | Jan 12, 2023 | May 01, 2023 | $0.150 | 0.85% |
FAQ
Click here for our free guide on how to buy Cyclacel Pharmaceuticals Inc Stock.
